New mutations in TK2 gene associated with mitochondrial DNA depletion
- PMID: 16504786
- DOI: 10.1016/j.pediatrneurol.2005.07.013
New mutations in TK2 gene associated with mitochondrial DNA depletion
Abstract
Mitochondrial deoxyribonucleic acid depletion syndromes are autosomal recessive disorders characterized by a reduction of the amount of mitochondrial deoxyribonucleic acid, which impairs the synthesis of respiratory chain complexes. Mutations in the deoxyguanosine kinase and polymerase gamma genes have been identified in hepatocerebral forms, whereas thymidine kinase 2 gene mutations have been found in patients with isolated myopathy, encephalomyopathy, or spinal muscular atrophy. Mutations in the gene encoding the beta subunit of the adenosine diphosphate-forming succinyl-coenzyme A synthetase have also been reported in a family. In this report, the clinical, molecular, morphologic, and biochemical features of five children from two independent families with an infantile encephalomyopathy are characterized. The affected children manifested muscle mitochondrial deoxyribonucleic acid depletion and three novel thymidine kinase 2 gene mutations. They consist of a homozygous substitution resulting in Ala to Val change at the highly conserved position 181 of thymidine kinase in the first family, and two heterozygous substitutions in the second family: a Cys to Trp change at residue 108 and a Leu to Pro change at residue 257 of the enzyme. Common clinical features associated with these TK2 mutations are a normal early developmental phase followed by psychomotor regression, encephalopathy often with epileptic seizures, and myopathy with features of a progressive dystrophic process.
Similar articles
-
Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.Arch Neurol. 2003 Jul;60(7):1007-9. doi: 10.1001/archneur.60.7.1007. Arch Neurol. 2003. PMID: 12873860
-
Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.Brain. 2008 Nov;131(Pt 11):2841-50. doi: 10.1093/brain/awn236. Epub 2008 Sep 26. Brain. 2008. PMID: 18819985
-
Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.Neuromuscul Disord. 2010 Mar;20(3):198-203. doi: 10.1016/j.nmd.2009.11.013. Epub 2010 Jan 18. Neuromuscul Disord. 2010. PMID: 20083405
-
Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene.Arch Neurol. 2006 Aug;63(8):1122-6. doi: 10.1001/archneur.63.8.1122. Arch Neurol. 2006. PMID: 16908738 Review.
-
Mitochondrial disease and epilepsy.Dev Med Child Neurol. 2012 May;54(5):397-406. doi: 10.1111/j.1469-8749.2011.04214.x. Epub 2012 Jan 28. Dev Med Child Neurol. 2012. PMID: 22283595 Review.
Cited by
-
Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future.Med Res Rev. 2008 Sep;28(5):797-820. doi: 10.1002/med.20124. Med Res Rev. 2008. PMID: 18459168 Free PMC article. Review.
-
Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.Acta Myol. 2009 Jul;28(1):2-11. Acta Myol. 2009. PMID: 19772189 Free PMC article.
-
Reduced mitochondrial DNA content and heterozygous nuclear gene mutations in patients with acute liver failure.J Pediatr Gastroenterol Nutr. 2013 Oct;57(4):438-43. doi: 10.1097/MPG.0b013e31829ef4b4. J Pediatr Gastroenterol Nutr. 2013. PMID: 23783014 Free PMC article.
-
Novel TK2 mutations as a cause of delayed muscle maturation in mtDNA depletion syndrome.Neurol Genet. 2016 Sep 14;2(5):e95. doi: 10.1212/NXG.0000000000000095. eCollection 2016 Oct. Neurol Genet. 2016. PMID: 27660820 Free PMC article.
-
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.EMBO Mol Med. 2014 Aug;6(8):1016-27. doi: 10.15252/emmm.201404092. EMBO Mol Med. 2014. PMID: 24968719 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical